FF
Insider buying
Fairmount Funds Management Llc bought $20M of Viridian Therapeutics, Inc.\DE (VRDN) stock
Fairmount Funds Management Llc, Dir, 10% of Viridian Therapeutics, Inc.\DE (VRDN), bought 1,176,470 shares of VRDN stock worth $20M, per an SEC Form 4 filed May 13, 2026.
It was an open-market purchase.
The trade happened on May 11, 2026, 2 days before it was made public.
VRDN has moved +25.5% since the trade date, from $17.20 to $21.58 (Sep 21, 2026 close).
- Traded
- May 11, 2026
- Disclosed
- May 13, 2026
- Filing delay
- 2 days
- Price since
- +25.5%
- Role
- Dir, 10%
- Source
- SEC Form 4
More VRDN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.